{"entity":{"type":"insider","cik":"0001360376","url":"/insider/0001360376","json_url":"/insider/0001360376.json","name":"Lasowski Juergen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":19,"first":"2006-05-11","last":"2013-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Lasowski Juergen","source":"filing","n_filings":19,"first_seen":"2006-05-11","last_seen":"2013-07-02"}],"transactions":[{"id":5196991,"accession":"0001179110-13-011357","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-011357","line_url":"/filing/0001179110-13-011357#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corp. Dev & Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Corp. Dev & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp. Dev & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25375.0,"shares_display":"25,375","price_per_share":132.63,"price_display":"132.63","price_state":"stated","total_value":3365486.25,"total_display":"3,365,486.25","total_whole":"3,365,486","shares_owned_after":32083.0,"shares_owned_after_display":"32,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-02","scope":"insider"},{"id":5161279,"accession":"0001179110-13-008589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-008589","line_url":"/filing/0001179110-13-008589","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corp. Dev & Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Corp. Dev & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp. Dev & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4182.0,"shares_display":"4,182","price_per_share":96.5966456241033,"price_display":"96.60","price_state":"stated","total_value":403967.172,"total_display":"403,967.17","total_whole":"403,967","shares_owned_after":33277.0,"shares_owned_after_display":"33,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-16","scope":"insider","n_lines":2},{"id":4622606,"accession":"0001179110-13-006443","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-006443","line_url":"/filing/0001179110-13-006443","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corp. Dev & Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Corp. Dev & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp. Dev & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2651.0,"shares_display":"2,651","price_per_share":86.1373179932101,"price_display":"86.14","price_state":"stated","total_value":228350.03,"total_display":"228,350.03","total_whole":"228,350","shares_owned_after":36265.0,"shares_owned_after_display":"36,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-04-03","scope":"insider","n_lines":3},{"id":2147673,"accession":"0001179110-12-014966","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-014966","line_url":"/filing/0001179110-12-014966#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corp. Dev & Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Corp. Dev & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corp. Dev & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5902.0,"shares_display":"5,902","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":531180.0,"total_display":"531,180.00","total_whole":"531,180","shares_owned_after":31816.0,"shares_owned_after_display":"31,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-05","filed_date":"2012-10-05","scope":"insider"},{"id":3501770,"accession":"0001209191-12-039433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-039433","line_url":"/filing/0001209191-12-039433#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5348.0,"shares_display":"5,348","price_per_share":73.9718,"price_display":"73.97","price_state":"stated","total_value":395601.1864,"total_display":"395,601.19","total_whole":"395,601","shares_owned_after":48968.0,"shares_owned_after_display":"48,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-25","filed_date":"2012-07-27","scope":"insider"},{"id":3171343,"accession":"0001209191-12-002331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-002331","line_url":"/filing/0001209191-12-002331#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1232.0,"shares_display":"1,232","price_per_share":42.64,"price_display":"42.64","price_state":"stated","total_value":52532.48,"total_display":"52,532.48","total_whole":"52,532","shares_owned_after":34000.0,"shares_owned_after_display":"34,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-05","scope":"insider"},{"id":9055875,"accession":"0001209191-11-046595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-046595","line_url":"/filing/0001209191-11-046595#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1006.0,"shares_display":"1,006","price_per_share":34.14,"price_display":"34.14","price_state":"stated","total_value":34344.84,"total_display":"34,344.84","total_whole":"34,345","shares_owned_after":35232.0,"shares_owned_after_display":"35,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-02","scope":"insider"},{"id":8997712,"accession":"0001209191-11-041817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-041817","line_url":"/filing/0001209191-11-041817#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1665.0,"shares_display":"1,665","price_per_share":33.27,"price_display":"33.27","price_state":"stated","total_value":55394.55,"total_display":"55,394.55","total_whole":"55,395","shares_owned_after":36238.0,"shares_owned_after_display":"36,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-01","filed_date":"2011-08-01","scope":"insider"},{"id":9063987,"accession":"0001209191-11-030584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-030584","line_url":"/filing/0001209191-11-030584","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":594.0,"shares_display":"594","price_per_share":43.02257575757576,"price_display":"43.02","price_state":"stated","total_value":25555.41,"total_display":"25,555.41","total_whole":"25,555","shares_owned_after":37241.0,"shares_owned_after_display":"37,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-20","filed_date":"2011-05-23","scope":"insider","n_lines":2},{"id":9018518,"accession":"0001209191-11-027302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-027302","line_url":"/filing/0001209191-11-027302#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3783.0,"shares_display":"3,783","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":151320.0,"total_display":"151,320.00","total_whole":"151,320","shares_owned_after":37832.0,"shares_owned_after_display":"37,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-06","filed_date":"2011-05-10","scope":"insider"},{"id":8884780,"accession":"0001209191-11-021302","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-021302","line_url":"/filing/0001209191-11-021302#line-3","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (EVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1478.0,"shares_display":"1,478","price_per_share":35.02,"price_display":"35.02","price_state":"stated","total_value":51759.56,"total_display":"51,759.56","total_whole":"51,760","shares_owned_after":41615.0,"shares_owned_after_display":"41,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-04","scope":"insider"},{"id":7693322,"accession":"0001209191-10-030048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-030048","line_url":"/filing/0001209191-10-030048","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":24.064533333333333,"price_display":"24.06","price_state":"stated","total_value":14438.72,"total_display":"14,438.72","total_whole":"14,439","shares_owned_after":13869.0,"shares_owned_after_display":"13,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-20","filed_date":"2010-05-24","scope":"insider","n_lines":2},{"id":7270504,"accession":"0001209191-10-020359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-020359","line_url":"/filing/0001209191-10-020359#line-2","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":739.0,"shares_display":"739","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":22243.9,"total_display":"22,243.90","total_whole":"22,244","shares_owned_after":14461.0,"shares_owned_after_display":"14,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-01","filed_date":"2010-04-02","scope":"insider"},{"id":5827329,"accession":"0001209191-09-040792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-040792","line_url":"/filing/0001209191-09-040792#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3182.0,"shares_display":"3,182","price_per_share":30.73,"price_display":"30.73","price_state":"stated","total_value":97782.86,"total_display":"97,782.86","total_whole":"97,783","shares_owned_after":9200.0,"shares_owned_after_display":"9,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-14","filed_date":"2009-08-14","scope":"insider"},{"id":5787256,"accession":"0001209191-09-037646","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-037646","line_url":"/filing/0001209191-09-037646","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8828.0,"shares_display":"8,828","price_per_share":35.98119619392841,"price_display":"35.98","price_state":"stated","total_value":317642.0,"total_display":"317,642.00","total_whole":"317,642","shares_owned_after":14942.0,"shares_owned_after_display":"14,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-22","filed_date":"2009-07-24","scope":"insider","n_lines":2},{"id":5786997,"accession":"0001209191-09-034083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-034083","line_url":"/filing/0001209191-09-034083","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3332.0,"shares_display":"3,332","price_per_share":26.270504201680673,"price_display":"26.27","price_state":"stated","total_value":87533.32,"total_display":"87,533.32","total_whole":"87,533","shares_owned_after":21222.0,"shares_owned_after_display":"21,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-26","filed_date":"2009-06-29","scope":"insider","n_lines":2},{"id":5606610,"accession":"0001209191-09-028138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-028138","line_url":"/filing/0001209191-09-028138#line-1","is_derivative":false,"issuer_cik":"0001012140","issuer_name":"ONYX PHARMACEUTICALS INC","issuer_ticker":"ONXX","issuer_name_source":null,"issuer_url":"/issuer/0001012140","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (SVP, Corporate Development)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1440.0,"shares_display":"1,440","price_per_share":23.75,"price_display":"23.75","price_state":"stated","total_value":34200.0,"total_display":"34,200.00","total_whole":"34,200","shares_owned_after":24542.0,"shares_owned_after_display":"24,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-21","scope":"insider"},{"id":3826084,"accession":"0001360376-06-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001360376-06-000001","line_url":"/filing/0001360376-06-000001#line-1","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (Senior VP Business Development)","role_mark":"O","role_mark_label":"Officer (Senior VP Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Business Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10600.0,"shares_display":"10,600","price_per_share":4.74,"price_display":"4.74","price_state":"stated","total_value":50244.0,"total_display":"50,244.00","total_whole":"50,244","shares_owned_after":20220.0,"shares_owned_after_display":"20,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-14","filed_date":"2006-06-15","scope":"insider"},{"id":3868233,"accession":"0001324517-06-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001324517-06-000028","line_url":"/filing/0001324517-06-000028#line-1","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001360376","owner_name":"Lasowski Juergen","owner_display_name":"Lasowski Juergen","owner_url":"/insider/0001360376","role":"Officer (Senior VP Business Development)","role_mark":"O","role_mark_label":"Officer (Senior VP Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Business Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9620.0,"shares_display":"9,620","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":50024.0,"total_display":"50,024.00","total_whole":"50,024","shares_owned_after":9620.0,"shares_owned_after_display":"9,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-10","filed_date":"2006-05-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001012140","name":"ONYX PHARMACEUTICALS INC","url":"/issuer/0001012140","role":"Officer (EVP, Corp. Dev & Strategy)","n_filings":17,"first_seen":"2009-05-21","last_seen":"2013-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000890465","name":"NPS PHARMACEUTICALS INC","url":"/issuer/0000890465","role":"Officer (Senior VP Business Development)","n_filings":2,"first_seen":"2006-05-11","last_seen":"2006-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001360376","retrieved_at":"2026-08-22T05:54:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}